N/A N=72 Metacognitive-Strategy Training in Sub-Acute Stroke
Stroke
Primary: Canadian Occupational Performance Measure (COPM) — 3.77; 3.87 score on a scale — p=.693
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=23 Exercise and Brain Stimulation for Post-stroke Depression
Stroke
Primary: Change From Baseline to Post Training in Hamilton Rating Scale for Depression — -2.75; -7.5; -7.83; -2.29 units on a scale
Phase 1 N=24 A Phase Ib/II in Patients With Acute Ischemic Stroke
Ischemic Stroke
Primary: Maximum Tolerated Dose (MTD) of DDFPe Evaluated by Number of Dose Limiting Toxicities — 0; 0; 0; 0 Dose Limiting Toxicities
Phase 2 N=18 Positional Therapy After Stroke
Sleep Apnea · Stroke
Primary: Apnea-hypopnea Index — 27; 39 events/hr — p=0.011
N/A N=58 Stimulating Language in Subacute StrokE
Stroke
Primary: Change in Accuracy of Naming Untrained Pictures (Philadelphia Naming Test (PNT)) Pre-treatment to 1 Week Post-treatment — 22.3; 18.5 score on a scale — p=0.54
Phase 2 N=12 A Rehabilitation Therapy for Post-stroke Fatigue
Stroke
Primary: Feasibility of Recruitment Process — 120; 49; 20; 12 participants
N/A N=11 Primed vs. Unprimed rTMS in Chronic Stroke
Stroke
Primary: Change in Cortical Excitability: Paired-Pulse — -18; 18; 12 milivolt
Phase 2 N=195 Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
Ischemic Stroke · Transient Ischemic Attack
Primary: Number of Participants With Intracranial Bleeding and/or Recurrent Ischemic Lesion as Confirmed by MRI Imaging — 47; 48 Participants
N/A N=4 Treatment of Hand Dysfunction After Stroke
Stroke
Primary: Fugl-Meyer Upper Limb Coordination Scale (FMUE) — 27.75; 48.50 units on a scale — p=.0001
Phase 4 N=543 EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA
Cerebrovascular Accident
Primary: Telephone Modified Rankin Scale (Centralised, Blinded Assessment) — 58; 70; 75; 84 participants — p=0.683
Phase 2 N=14 Cough and Swallow Rehab Following Stroke
Ischemic Stroke
Primary: Maximum Expiratory Pressure — 104.31 cm H2O (pressure measurement) — p=.001
N/A N=10 Pilot of Cognitive Stimulation Therapy for Pre-frail Stroke Survivors
Stroke · Frailty · Carers
Primary: Framework Analysis Using the Theoretical Framework of Acceptability as a Guiding Framework — 4; 4; 4; 4 Participants
Phase 2 N=19 Combined Transcranial Direct Current Stimulation and Motor Imagery-based Robotic Arm Training for Stroke Rehabilitation
Stroke
Primary: Upper Extremity Component of Fugl-Meyer Assessment — 35.3; 32.6; 0.9; 0.8 units on a scale
N/A N=757 Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
Depression · Breast Cancer Screening · Cervical Cancer Screening
Primary: Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status — 22.0; 26.9; 56.9; 52.8 Percentage (%) of Participants — p=0.2562
N/A N=3 SCED - Wisdom Enhancement for Post-Stroke Depression
Post-stroke Depression
Primary: Visual Analogue Scale (VAS) - Mood — 3.53; 5.23 Scores on a scale